phase 3 | sciencenewsnet.in

Breaking News

Beyond Higher Temperatures: Preparing for National Security Risks Posed by Climate Change

Extracting High-Purity Gold from Electrical and Electronic Waste

Innovation Tri-Valley Leadership Group and the Hertz Foundation Announce Partnership to Celebrate World-Class Talent

AANA Presents Excellence in State Government Relations Advocacy Award to Georgia

Being treated by a female physician associated with lower risk for death

Firearm violence risk score may help tailor, disseminate prevention efforts in emergency departments

ACP recommends an evidence-based public health approach to excessive alcohol use

System-level factors influence doctors to reduce low-value care practices

Treatment from female doctors leads to lower mortality and hospital readmission rates

Historical redlining associated with higher rate of firearm fatalities

23 Apr, 2024

Are Too Many Phase III Cancer Clinical Trials Set Up to Fail?

September 23, 2021 sarah JonasResearch Results

New research in JNCCN finds four out of five cancer therapies tested in Phase III trials do not achieve clinically-meaningful benefit in prolonging survival, and is the first study to quantify the number of false-positive, false-negative, and true-negative trial results.

Baylor Scott & White Health Enrolls First Patients in the World in Trial for Inhaled Remdesivir

October 2, 2020 sarah JonasFeature

Earlier this month, Baylor Scott & White Research Institute enrolled the first four patients in the world on Gilead’s new clinical trial involving an investigational inhaled solution of remdesivir (NCT04539262). This is Gilead’s first trial in COVID-19 patients examining the safety and efficacy of an inhaled solution of the drug in an outpatient setting. The study of an inhaled solution asks whether this mode of delivery can help reduce the amount of virus from the airways earlier.